Microbiome Therapeutics
Membership Organizations · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11001 W 120th Ave Ste 400, Broomfield, C...Phone Number
(609) 216-1203Website
www.microbiometig.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Microbiome Therapeutics
The Microbiome Therapeutics Innovation Group (MTIG) is a coalition of companies focused on advancing the research and development of FDA-approved microbiome therapeutics and microbiome-based products. Their mission is to enhance the regulatory, investment, and commercial landscape to accelerate the development of these life-changing therapies. MTIG aims to address unmet medical needs and improve clinical outcomes for patients suffering from various diseases. Membership is open to pharmaceutical and biotechnology companies seeking regulatory approvals in this innovative field.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Microbiome Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Microbiome Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Microbiome Therapeutics
Website visits: Recent activity has been detected on your website
Click to see if Microbiome Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Microbiome Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Microbiome Therapeutics has new funding data
Microbiome Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Microbiome Therapeutics launches new products
Check if Microbiome Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Microbiome Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Microbiome Therapeutics
Compare insights from companies similar to Microbiome Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Microbiome Therapeutics
<$5M
1-10
Private
-
2009
N/A
<$5M
11-50
Private
$555M
2018
PR
Paul ReinfeldsSenior Vice President - Legal Affairs and General Counsel
Company Profile Activity
Activity Insights
Microbiome Therapeutics is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Microbiome Therapeutics is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Microbiome Therapeutics.
Microbiome Therapeutics Tech Stack
A closer look at the technologies used by Microbiome Therapeutics
See more technologies
Microbiome Therapeutics News & Media
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration AgreementMaaT Pharma Joins Microbiome Therapeutics Innovation Group
WASHINGTON, July 20, 2023 /PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of MaaT Pharma to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products to...Microbiome Therapeutics Innovation Group Announces New Chairman
WASHINGTON, July 5, 2022 /PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG), an independent 501(c)(6) coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve...Bio-Me Joins Microbiome Therapeutics Innovation Group
WASHINGTON, April 25, 2022 /PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of Bio-Me to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products. Bio-Me...
Read more news
Top Membership Organizations Companies
See more top companies
Frequently Asked Questions Regarding Microbiome Therapeutics
Sign Up For FreeTo access detailed company insights
The Microbiome Therapeutics Innovation Group (MTIG) is a coalition of companies focused on advancing the research and development of FDA-approved microbiome therapeutics and microbiome-based products. Their mission is to enhance the regulatory, investment, and commercial landscape to accelerate the development of these life-changing therapies. MTIG... Read More
